The National Institute for Health and Care Excellence (NICE) has published four new rapid guidelines on the active management of patients with suspected and confirmed COVID-19, and in patients without COVID-19.
The guidelines, which are designed to maximise the safety of patients whilst enabling services to make the best use of NHS resources, cover the management of patients with severe asthma, pneumonia, rheumatological autoimmune, inflammatory and metabolic bone disorders and the management of COVID-19 symptoms in the community.
COVID-19 rapid guideline: severe asthma
People should continue to take their treatment as prescribed and only attend essential appointments alone, if possible, to minimise the risk of infection…
